Form 4: Alkermes VP of Finance Samuel Joseph Parisi Reports Stock Transactions

Samuel Joseph Parisi, VP of Finance (Interim PAO) at Alkermes plc, reported the vesting of restricted stock units, subsequent sale of shares, and tax withholding.

Summary

• On February 26, 2025, Samuel Joseph Parisi, VP of Finance (Interim PAO) at Alkermes plc, had 2,746 restricted stock units vest.
• Following the vesting, Parisi disposed of 10,463 ordinary shares.
• 808 shares were disposed of to cover tax obligations at a price of $34.795 per share.
• On February 28, 2025, Parisi sold 1,938 shares at $34 per share.
• After these transactions, Parisi directly owns 7,717 ordinary shares.
• The sale on February 28, 2025, was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice for publicly traded companies. It provides transparency into the trading activities of key personnel and helps investors assess management's perspective on the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The transactions reported are typical for executives receiving stock-based compensation.
• The use of a 10b5-1 trading plan is a common method for insiders to sell shares while avoiding accusations of insider trading, similar to practices at companies like Pfizer or Merck.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company insider.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates